TuHURA Biosciences, Inc..
HURA.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
TuHURA Biosciences, Inc. is a biopharmaceutical company focused on the discovery and development of novel, next-generation immunotherapies for the treatment of cancer. The company's pipeline includes preclinical and clinical-stage assets designed to harness the power of the immune system to fight ca...Show More
Better Health for All
0
TuHURA Biosciences is a biopharmaceutical company dedicated to improving the lives of cancer patients through novel immunotherapies. Its lead product, IFx-2.0, is in a Phase 3 trial for advanced or metastatic Merkel cell carcinoma, a severe condition.
1
Phase 1b trial results showed a 63% overall response rate, including 2 complete and 5 partial responses, with durations up to 33 months, indicating exceptional health benefits.
2
The company currently has no revenue from products with negative health impacts, as its sole focus is on developing health-positive therapies. However, the FDA placed a partial clinical hold on the Phase 3 trial in late January 2025 due to manufacturing-related issues, which was later removed in June 2025.
3
This regulatory action suggests basic ethical standards with some gaps in trial conduct related to manufacturing.
Fair Money & Economic Opportunity
0
No evidence available to assess TuHURA Biosciences, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess TuHURA Biosciences, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence was provided in the articles regarding TuHURA Biosciences, Inc.'s performance on fair trade and ethical sourcing KPIs.
1
The provided article pertains to Previan Technologies Inc. and not the company under assessment.
2
Honest & Fair Business
0
No specific, concrete data points were found across the provided articles for any of the KPIs related to Honest & Fair Business. The articles primarily discuss financing, mergers, board experience, and changes in accounting firms, without detailing ethical performance metrics, regulatory fines, transparency scores, or specific policies related to whistleblowers or anti-corruption. While an FDA partial clinical hold was mentioned,
1
it does not constitute an ethics-related regulatory fine as defined by the rubric.
Kind to Animals
-50
TuHURA Biosciences conducts animal studies as a required part of its drug development process, including preclinical testing.
1
The company states it complies with "applicable requirements for the humane use of laboratory animals or other applicable regulations," which is a vague policy statement.
2
Over 1,200 doses of its cancer vaccine, ImmuneFx, have been administered to dogs, cats, and horses for over 30 different types of cancers.
3
The company is also working to get approval through the U.S. Department of Agriculture (USDA) for other projects involving animals.
4
No War, No Weapons
10
TuHURA Biosciences is a biopharmaceutical company focused on developing cancer immunotherapies.
1
Its R&D is exclusively dedicated to medical treatments, such as innate immune response agonists and VISTA-blocking immunotherapies, which are humanitarian technologies.
2
There is no evidence of any revenue derived from arms or defense contracts, nor does the company develop or sell dual-use products with military applications.
3
Furthermore, there is no indication of any exposure to controversial or banned weapons.
4
Planet-Friendly Business
0
No quantitative data or specific evidence related to Planet-Friendly Business metrics for HURA.US was found in the provided articles.
1
All articles explicitly state that sustainability data is currently unavailable for HURA.US, or they refer to a different company (CohBar Inc.).
2
Therefore, no KPIs can be scored.
Respect for Cultures & Communities
0
No evidence available to assess TuHURA Biosciences, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-40
TuHURA Biosciences states that users have choices regarding their personal information, including the ability to withdraw consent, unsubscribe from emails, restrict technologies, and request access, portability, correction, deletion, and restriction of processing.
1
California residents are also afforded specific rights under the CCPA.
2
However, the ease of exercising these rights or the presence of a comprehensive privacy dashboard is not detailed. The company collects various types of personal information, including name, email, phone number, mailing address, date of birth, and medical history for service enrollment or clinical trial matching, as well as automatically collected data like IP addresses and device information.
3
This data is retained as long as services are used or as necessary to fulfill the purpose for which it was collected, resolve disputes, establish legal defenses, conduct audits, pursue legitimate business purposes, enforce agreements, and comply with applicable laws, suggesting retention periods of 3-5 years for most data.
4
The company states it takes steps to ensure information is treated securely, prohibits users from breaching security measures or testing system vulnerabilities, and mentions detecting security incidents and debugging errors.
5
It also verifies identity before fulfilling privacy requests.
6
The company has a Privacy Policy available and states compliance with legal obligations, including the CCPA.
7
Zero Waste & Sustainable Products
0
No evidence available to assess TuHURA Biosciences, Inc. on Zero Waste & Sustainable Products.